Novocell News
Most Popular Novocell Story
Pfizer gambles up to $111M on Athersys' stem cell therapy
In a fresh indication of Big Pharma's desire to tap into the future revenue potential presented by stem cell therapies, Pfizer has inked a $111 million deal to license rights to develop Athersys' Read more...
Latest Headlines
- December 21, 2009
- May 1, 2009
- April 11, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
